News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Natera and Solstas Lab Partners Enter Distribution Agreement for Non-Invasive Prenatal Test, Panorama™



9/18/2013 10:01:58 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GREENSBORO, N.C., & SAN CARLOS, Calif.--(BUSINESS WIRE)--Solstas Lab Partners®, one of the nation's fastest-growing full-service laboratories, and Natera, a leading innovator in reproductive and prenatal genetic testing, today announced a distribution agreement that will make Natera’s non-invasive prenatal screening test, Panorama™, available to Solstas’ clients nationwide. Panorama was launched earlier this year for the detection of trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome) and select sex chromosome abnormalities, such as monosomy X (Turner syndrome). In August 2013 detection of triploidy was added.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Natera
 
 
Pregnancy

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES